StoneWise AI Ltd.

StoneWise is an AI-enabled platform for small molecule drug discovery that started in 2018. Our AI technology platform has focused on developing a robust molecule generative model, facilitating chemists in exploring the huge chemical space with greater accessibility. Moreover, we integrate computational chemistry (CADD) and informatics tools, the "dry" technologies, alongside chemistry capabilities, the "wet lab“ practices, enhancing our capabiltiy toward HIT identification and Hit-lead processes. Through this integrated approach, we offer service to our customers. The team delivers a series of early-stage drug candidates over a short time frame and our unique algorithms are improving daily.